Compare Stocks

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABC ABcann Global		C$0.00	C$0.00 ▼ C$0.00	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	$0.00	$0.00	$0.51 ▼ $2.05	$111K	N/A	136,653 shs	1,000 shs
CRON Cronos Group	$2.41	$2.32	$1.64 ▼ $2.99	$920.64M	1.17	2.85 million shs	41,400 shs
GNS Genius Group	$0.39 -0.7%	$0.00	$0.24 ▼ $2.48	$28.80M	11.9	6.04 million shs	320,268 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRON Cronos Group	-0.41%	-5.12%	+5.24%	+20.50%	+24.23%
GNS Genius Group	0.00%	0.00%	0.00%	0.00%	-80.74%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABC ABcann Global	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	1.708 of 5 stars	2.2	5.0	0.0	0.0	3.3	0.0	1.3
GNS Genius Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABC ABcann Global	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A	N/A
CRON Cronos Group	2.33	Hold	$2.83	17.57% Upside
GNS Genius Group	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest GNS, AST, ABC, and CRON Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/8/2024	CRON Cronos Group	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$2.00 ➝ $2.50

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABC ABcann Global	N/A	N/A	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	$87.24M	10.55	N/A	N/A	$2.87 per share	0.84
GNS Genius Group	$18.19M	1.58	N/A	N/A	$0.50 per share	0.78

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABC ABcann Global	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	-$73.96M	-$0.19	N/A	80.33	N/A	-84.15%	-3.99%	-3.87%	5/14/2024 (Estimated)
GNS Genius Group	-$55.05M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest GNS, AST, ABC, and CRON Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/29/2024	Q4 2023	CRON Cronos Group	N/A	-$0.05	-$0.05	$0.02	$25.15 million	$23.92 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABC ABcann Global	N/A	N/A	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A
GNS Genius Group	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABC ABcann Global	N/A	N/A	N/A
AST Asterias Biotherapeutics	N/A	N/A	N/A
CRON Cronos Group	N/A	22.54	21.81
GNS Genius Group	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ABC ABcann Global	N/A
AST Asterias Biotherapeutics	N/A
CRON Cronos Group	8.71%
GNS Genius Group	14.28%

Insider Ownership

Company	Insider Ownership
ABC ABcann Global	N/A
AST Asterias Biotherapeutics	N/A
CRON Cronos Group	1.96%
GNS Genius Group	51.19%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABC ABcann Global	N/A	N/A	N/A	Not Optionable
AST Asterias Biotherapeutics	N/A	55.66 million	N/A	Not Optionable
CRON Cronos Group	356	382.01 million	374.52 million	Optionable
GNS Genius Group	475	73.87 million	36.06 million	Not Optionable

GNS, AST, ABC, and CRON Headlines

Source	Headline
	Genius Group Launches Its First Sovereign AI Education Ecosystem: Details msn.com - April 12 at 2:07 PM
	Genius Group Launches Genius City Singapore: Company's 1st Sovereign AI Education Ecosystem globenewswire.com - April 12 at 8:00 AM
	Genius Group (NYSEAMERICAN:GNS) Stock Price Down 2.3% americanbankingnews.com - April 11 at 2:34 AM
	Genius Group launches AI Avatar Toolkit for Global Faculty to build their own AI Tutors globenewswire.com - April 5 at 8:00 AM
	Genius Group announces the appointment of Mr. Adrian Reese as Chief Financial Officer markets.businessinsider.com - March 26 at 12:32 PM
	Genius Group announces the appointment of Mr. Adrian Reese as Chief Financial Officer finance.yahoo.com - March 26 at 12:32 PM
	What's Going On With Edtech Company Genius Shares Today? msn.com - March 22 at 9:52 AM
	Genius Group Updated 2024 Financial Guidance: $105 million to $110 million revenue with $6.0 million to $7.0 million positive EBITDA globenewswire.com - March 21 at 5:00 PM
	Toby Keith Elected Into Country Music Hall of Fame, in Voting That Wrapped Up Days Before His Death nz.finance.yahoo.com - March 18 at 3:41 PM
	Genius Group announces merger with OpenExO msn.com - March 18 at 3:41 PM
	Genius Group and OpenExO Sign Merger Agreement, Accelerating Plans to Build Global AI Education Group globenewswire.com - March 18 at 1:00 PM
	Genius Group Limited: Genius Group Release Additional Details of FatBrain AI Transaction finanznachrichten.de - March 18 at 10:40 AM
	Genius Group Release Additional Details of FatBrain AI Transaction globenewswire.com - March 18 at 7:00 AM
	Genius Group to Host Genius Investor Call on 21 March, 2024 Providing Revised Post-merger 2024 Guidance and Roadmap globenewswire.com - March 15 at 3:35 PM
	Genius Group Limited: Genius Group Completes FatBrain AI Merger, 150% Increase in 2023 Combined Proforma Revenue Guidance finanznachrichten.de - March 15 at 5:54 AM
	Genius Group Completes FatBrain AI Merger, 150% Increase in 2023 Combined Proforma Revenue Guidance globenewswire.com - March 14 at 2:10 PM
	Genius Group launches AI Avatar C-Suite, Featuring Einstein, Michelangelo & George Washington finance.yahoo.com - March 7 at 8:11 AM
	Genius Group expands AI-Powered Genius University globenewswire.com - February 26 at 7:00 AM
	Genius Group launches AI Avatar Tutor Team on GeniusU finance.yahoo.com - February 14 at 8:36 AM
	Genius Group launches AI Avatar Tutor Team on GeniusU globenewswire.com - February 14 at 7:00 AM
	boygenius: the supergroup whose synergy reinvigorated rock msn.com - February 4 at 8:11 AM
	What's Going On With Genius Group Stock? msn.com - January 24 at 3:18 PM
	GNS Stock Alert: Genius Group Is Merging with FatBrain AI investorplace.com - January 24 at 11:15 AM
	Genius Group Agrees To Merger With FatBrain AI markets.businessinsider.com - January 24 at 10:17 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Disney Stock Catches 3 Upgrades In a Single Week
March 28, 2024 10:27 AM
View Disney Stock Catches 3 Upgrades In a Single Week
Breakout Alert: Coinbase's Consolidation Is About To End
April 12, 2024 9:45 AM
View Breakout Alert: Coinbase's Consolidation Is About To End
Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
April 11, 2024 12:07 PM
View Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down

All Headlines

Company Descriptions

ABcann Global

CVE:ABC

Asterias Biotherapeutics

NYSEAMERICAN:AST

Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.

Cronos Group

NASDAQ:CRON

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Genius Group

NYSEAMERICAN:GNS

Genius Group Limited, through its subsidiaries, provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company operates through two segments, Education and Campus. It develops comprehensive entrepreneurial education curriculum with a full suite of tools for student learning and faculty earning. The company also owns entrepreneur resorts in Bali and South Africa, which run entrepreneur retreats and workshops; and Genius Café, an entrepreneur beach club in Bali, as well as Genius Central, an entrepreneur co-working hub in Singapore. In addition, it offers home childcare and investment education services; operates entrepreneur education campus that provides a range of programs from pre-primary through primary school, secondary school, and vocational college; and provides career-focused on-campus and online programs at the master's, bachelor's and associate degree level, as well as certificate and continuing education programs. The company operates in Europe/the Middle East/Africa, the Asia/Pacific, and North America/South America. Genius Group Limited was founded in 2002 and is headquartered in Singapore.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial